Skip to content

DNA Weekly Interview

In an interview with DNA Weekly (link:, CEO Umut Ağyüz discusses the advancements and future impact of Genz Biotechnology. Genz is a biotech company focused on developing innovative and accessible diagnostic solutions. Their primary areas of focus include early cancer diagnosis and addressing new pandemics. The company has developed the GENZPRO lab-accurate point-of-care testing system and aims to lead the market in POC diagnostics. Genz believes in the importance of personalized medicine and anticipates the rise of technologies supporting point-of-care patient tracking. They envision a future with larger capacity diagnostic devices for mass testing and smaller, portable devices for home or clinic use. Genz is committed to contributing to the development of testing reagent technologies.

Leave a Reply

Your email address will not be published. Required fields are marked *